GSK plc - Sep 27, 2024 Form 4 Insider Report for Wave Life Sciences Ltd. (WVE)

Role
10%+ Owner
Signature
/s/ Victoria Whyte, Authorized Signatory, GSK plc
Stock symbol
WVE
Transactions as of
Sep 27, 2024
Transactions value $
$22,335,440
Form type
4
Date filed
10/1/2024, 05:54 PM
Previous filing
Jan 30, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction WVE Ordinary Shares Purchase $22.3M +2.79M +19.97% $8.00 16.8M Sep 27, 2024 By Corporation F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares reported herein are held of record by Glaxo Group Limited, a wholly-owned subsidiary of GSK plc (the "Reporting Person").